[Clinical use of eprazinon-dihydrochloride (Eftapan)].
D000995:Antitubercular Agents / Q000008:administration & dosage; D001991:Bronchitis / Q000188:drug therapy; D004341:Drug Evaluation; D006801:Humans; D008297:Male; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011427:Propiophenones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000995:Antitubercular Agents; D010879:Piperazines; D011427:Propiophenones; C007608:eprazinone
Klinische Anwendung von Eprazinon-dihydrochlorid (Eftapan).